<DOC>
	<DOC>NCT02256579</DOC>
	<brief_summary>This study is to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.</brief_summary>
	<brief_title>Utility of Urinary beta2 Microglobulin as an Early Marker of Renal Dysfunction in Vietnamese HIV-Infected Patients</brief_title>
	<detailed_description>An observational study to investigate clinical utility of beta2 microglobulin as an early marker for renal dysfunction caused by Tenofovir in Vietnamese HIV-infected patients.</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>HIVinfected patients in the NHTD ACC cohort who are under cART or will start cART and can provide written informed consents. HIVinfected patients who drop out of treatment within 6 months from the entry.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>TDF:Tenofovir, Urine beta2microglobulin</keyword>
</DOC>